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An immediate consequence of traumatic brain injury (TBI) is the induction of an inflam-
matory response. Mounting data suggest that inflammation is a major contributor to
TBI-induced brain damage. However, much remains unknown regarding the induction and
regulation of the inflammatory response toTBI. In this study we compared theTBI-induced
inflammatory response to severe parenchymal injury (controlled cortical impact) vs. mild
brain injury (craniotomy) over a 21-day period. Our data show that both severe and mild
brain injury induce a qualitatively similar inflammatory response, involving highly overlap-
ping sets of effector molecules. However, kinetic analysis revealed that the inflammatory
response to mild brain injury is of much shorter duration than the response to severe TBI.
Specifically, the inflammatory response to severe brain injury persists for at least 21 days,
whereas the response to mild brain injury returns to near baseline values within 10 days
post-injury. Our data therefore imply that the development of accurate diagnostic tests of
TBI severity that are based on imaging or biomarker analysis of the inflammatory response
may require repeated measures over at least a 10-day period, post-injury.
Keywords: traumatic brain injury, inflammation, genomics, glia, response to injury, mouse models, cytokines,
diagnostics
INTRODUCTION
A major component of the biological response to traumatic brain
injury (TBI) is induction of inflammation. TBI, like other forms
of tissue injury, induces an immune response which is a form
of sterile inflammation. This type of immune response is driven
by the release of intracellular antigens which are normally hid-
den from leukocytes (Medzhitov, 2008; Chen and Nunez, 2010).
A subset of these hidden antigens is highly immunogenic, driving
immune activation by many of the same mechanisms employed
in responses to pathogenic organisms. Specifically, certain autol-
ogous hidden antigens bind to and activate the same pattern
recognition receptors [PRRs; e.g., toll-like receptors (TLRs)] that
are the receptors for specific pathogen products. For example,
TLR4 serves as the receptor for both bacterial lipopolysaccharide
(LPS) and a number of hidden self-antigens, including HMGB1,
hyaluronan, and specific proteins of the S100 family (Medzhitov,
2008; Chen and Nunez, 2010).
Toll-like receptors and other PRRs are found on many cell
types throughout the body. However, hidden self-antigen medi-
ated activation of such receptors on specific sentinel cells, particu-
larly macrophages, triggers the initial release of pro-inflammatory
cytokines, such as IL-1β. This cytokine response results in rapid
activation of local blood vessel endothelial cells, resulting in
recruitment of leukocytes from the blood stream, particularly neu-
trophils and monocytes. These phagocytic cells remove dead cells
and other debris in the injured tissue, as well as performing a
variety of other functions that promote tissue repair (Chen and
Nunez, 2010).
In the case of brain injury, substantial evidence suggests
that the PRR-expressing sentinel cells that initially trigger the
injury-associated inflammatory response are brain tissue-resident
macrophages (microglia) and astrocytes. The pro-inflammatory
cytokines produced by microglia and astrocytes then initiate
endothelial cell activation and recruitment of blood leukocytes
(Fitch and Silver, 2008; Whitney et al., 2009), analogous to the
inflammatory cascade that occurs in other tissues throughout the
body. Although post-TBI inflammation plays an essential role in
the healing response, there is also much evidence that the inflam-
matory response contributes to the death of bystander cells in
the brain tissue that were not directly damaged by TBI (Loane and
Byrnes, 2010). Furthermore, aspects of the inflammatory response
may favor the formation of scar tissue (i.e., the glial scar), while dis-
favoring neuroregeneration (Fitch and Silver, 2008; Whitney et al.,
2009; Griffiths et al., 2010; Neher et al., 2011). Thus, a detailed
understanding of the inflammatory response to TBI is a neces-
sary component in the effort to formulate successful strategies to
diminish bystander cell injury and to promote neuroregeneration.
One of the gaps in the understanding of the biological response
to TBI is how the magnitude of the injury influences the qualita-
tive, quantitative, and kinetic characteristics of the inflammatory
www.frontiersin.org October 2012 | Volume 3 | Article 155 | 1
Lagraoui et al. Inflammation in traumatic brain injury
response. A recently published study using a rat model of TBI (in
which members of our team participated) included the interesting
finding that specific inflammatory mediators were produced in sig-
nificant amounts in response to craniotomy. This study assessed
a small collection of cytokine protein levels at days+1 and +7
post-injury, comparing tissues from craniotomy vs. naïve animals
(Cole et al., 2011). However, as there was no comparison to a
more severe brain injury in this study, it was not possible to deter-
mine how the observed cytokine levels induced by craniotomy
compare to the cytokine response to more severe injury of the
parenchyma.
Therefore, to extend the findings of this previous report, we
initiated a study in mice to determine to what degree the mag-
nitude and kinetics of the inflammatory response to severe and
mild brain injury differ (note that the inflammatory response
to TBI in mice and rats is highly similar Natale et al., 2003).
To address this question, we performed histological, behavior,
protein, and global gene expression analyses comparing a model
of severe parenchymal injury [controlled cortical impact (CCI);
Lighthall, 1988] to mild brain injury (craniotomy). Our data
show that both severe and mild brain injury induce a qual-
itatively similar inflammatory response, involving highly over-
lapping sets of genes. However, kinetic analysis revealed that
the inflammatory response to mild brain injury is of much
shorter duration than the response to severe TBI, allowing
severe- and mild-TBI to be readily discriminated at day +10
post-injury and beyond. These data therefore have implications
for the diagnosis of TBI severity. Specifically, the development
of accurate diagnostic tests of TBI severity that are based on
imaging or biomarker analysis of the inflammatory response
may require repeated measures over at least a 10-day period,
post-injury.
MATERIALS AND METHODS
ANIMALS AND SURGICAL PROCEDURES
Ten- to twelve-week old C57BL/6 male mice were subjected to
TBI using an Impact One™Stereotaxic Impactor (myNeuroLab,
St. Louis, MO, USA). Briefly, mice were anesthetized with 2%
isoflurane in 98% oxygen, and were then positioned in the stereo-
taxic frame. Craniotomy was performed by a single skilled surgeon
using a hand-held 5 mm trephine over the motor cortex (1.8 mm
medial-lateral, 2 mm from Bregma). Mice were then subjected
to CCI using a 3 mm flat-tip with a velocity of 5 m/s, a depth
of 2.0 mm, and a duration of 200 ms. After trauma, the cran-
iotomy was closed with the previously removed bone and bone
wax, and the incision was closed with sutures. Craniotomy ani-
mals underwent the same procedure as the CCI group, except that
the stereotaxic impactor was not used. Craniotomies were per-
formed with great care, in order to avoid disruption of the dura. A
few mice in the CCI group displayed slight hemorrhage, primar-
ily on days +1 and +3 post-CCI. When hemorrhage was present,
the wound was cleaned prior to tissue harvest. There was no visi-
ble hemorrhage in any craniotomy-only animal. Naïve mice were
anesthetized with 2% isoflurane in 98% oxygen, monitored until
recovery from anesthesia, and transferred to fresh cages. The Insti-
tutional Animal Care and Use Committee at Uniformed Services
University (USU) approved all animal procedures.
HISTOLOGY
For hematoxylin and eosin (H&E) staining, brains were harvested
from CCI, craniotomy, and naïve animals at day +7. Brains were
perfused with 1×PBS then fixed and stored in 4% paraformalde-
hyde. Tissue embedding, processing, and H&E staining were
performed by Histoserv Inc. Note that the dura was lost from
some regions of craniotomy and naïve brains during sectioning,
although it was intact at the time of tissue harvest. Histology slides
were viewed and scanned using the Nanozoomer Digital Pathology
version 2.0-RS (Hamamatsu Photonics, Japan). Nanozoomer data
were analyzed using NDP viewer software (Hamamatsu Photonics,
Japan).
For immunofluorescence microscopy analysis, mice were per-
fused with a cold solution of 4% paraformaldehyde in 1×PBS,
followed by immediate brain harvest and 8–10 h cryopreserva-
tion in 30% sucrose. Brains were then frozen in Tissue-Tek OCT
(Sakura Finetek, Torrance, CA, USA) and stored at −80˚C. Coro-
nal cryosections (20µm) were collected and stored at−80˚C until
immunostaining with the anti-GFAP antibody.
TISSUE HARVESTING AND RNA EXTRACTION
Animals were sacrificed on days +1, +2, +3, +7, +10, and +21.
Mice were perfused with 1×PBS and brains were collected. Two
brain regions were harvested from naïve, craniotomy and CCI
mice: a 5 mm diameter punch biopsy encompassing the exact
injury site on the left hemisphere and another 5 mm biopsy recov-
ering the equivalent non-injured (contralateral) site on the right
hemisphere. The depth of the punch was approximately 5 mm,
penetrating the base of the brain. RNA was extracted from the
biopsy tissue using guanidinium isothiocyanate-phenol extraction
(Chomczynski and Sacchi, 1987).
REAL-TIME PCR ANALYSES
The above RNA samples (2µg) were reverse transcribed to cDNA,
using random hexamers and Superscript II Reverse Transcriptase
(Life Technologies, Carlsbad, CA, USA), in a 1-h reaction at 42˚C.
Real-time PCR analysis of cDNA was performed using an RT-PCR
master mix for TaqMan assays (SydLabs, Inc., Malden, MA, USA)
and an iQ5 instrument (Bio-Rad, Hercules, CA, USA) in 96-well
format with 20µl reaction volume per well. Primers for Taq-
Man assays were designed using Primer Express 3.0 software (Life
Technologies, Carlsbad, CA, USA). PCR primers and FAM-ZEN
double-quenched probes were purchased from IDT (Coralville,
IA, USA). Primer sequences are listed in Table 1. GAPDH was
used as a normalization control for all probe sets. Samples were
collected from both the ipsilateral and contralateral sites. Three
or four mice were used for each experimental group at each time
point.
The delta Ct (∆Ct) method was used for PCR array data analy-
sis. The normalized ∆Ct for each gene of interest (GOI) was
calculated by deducting the Ct of the housekeeping gene (HKG:
GAPDH) from the Ct of each GOI: ∆Ct =
(
CGOIt − CHKGt
)
.
The ∆∆Ct for each GOI was calculated by deducting the aver-
age ∆Ct of GOI in the naïve or craniotomy group from the ∆Ct
of each GOI in the CCI group: ∆∆Ct=∆Ct (CCI group) – aver-
age ∆Ct (naïve or craniotomy group). The fold-change of each
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Table 1 | Real-time PCR primers.
CCL2
Sense GGCTCAGCCAGATGCAGTTAA
Anti-sense CCTACTCATTGGGATCATCTTGCT
Probe CCCCACTCACCTGCTGCTACTCATTCA
IL-1β
Sense GAGCACCTTCTTTTCCTTCATCTT
Anti-sense CACACACCAGCAGGTTATCATCA
Probe AGAAGAGCCCATCCTCTGTGACTCATGG
TNF-α
Sense GGTCCCCAAAGGGATGAGAA
Anti-sense TGAGGGTCTGGGCCATAGAA
Probe TTCCCAAATGGCCTCCCTCTCATCA
AQP4
Sense GGTTGGAGGATTGGGAGTCA
Anti-sense GTGAACACCAACTGGAAAGTGATT
Probe CACGGTTCATGGAAACCTCACCGC
VIMENTIN
Sense GGAGATGCTCCAGAGAGAGGAA
Anti-sense GTGCCAGAGAAGCATTGTCAAC
Probe CGAAAGCACCCTGCAGTCATTCAGACA
MMP3
Sense TGATGAACGATGGACAGAGGAT
Anti-sense AGCCTTGGCTGAGTGGTAGAGT
Probe TTGCTGCTCATGAACTTGGCCACTCC
SAA3
Sense CGCAGCACGAGCAGGAT
Anti-sense GCTGTCAACTCCCAGGATCAA
Probe AGCCTTCCATTGCCATCATTCTTTGCA
C3
Sense GCCAAGGACTGCAGACTGAAC
Anti-sense CACTTCCGAAGACCCTTGTCA
Probe CGCCGCCGTCGCTCAGTACAGT
GAPDH
Sense TGTGTCCGTCGTGGATCTGA
Anti-sense CCTGCTTCACCACCTTCTTGA
Probe CCGCCTGGAGAAACCTGCCAAGTATG
Sequences of primers (5′ to 3′) used forTaqMan real-time PCR are listed. All hydrol-
ysis probes were FAM-labeled and included an internal ZEN quencher. Each PCR
amplicon crosses a splice junction.
GOI compared to the naïve or craniotomy group was calculated
as: Fold-change= 2(−∆∆Ct).
ELECTROCHEMILUMINESCENT IMMUNOASSAY ANALYSIS OF
CYTOKINES IN BRAIN HOMOGENATES
Brain homogenates were prepared from punch biopsies (5 mm
diameter cannula) from the injury and contralateral sites. Tissue
was weighed and homogenized in 10 volumes per weight of T-Per
extraction buffer (Pierce Biotechnology, Rockford, IL, USA) with
Halt protease Inhibitor (Pierce Biotechnology, Rockford, IL, USA)
utilizing a Bioruptor UCD-200 ultrasonic disruptor (Diagenode,
Sparta, NJ, USA), as previously described (Cole et al., 2011).
Total protein concentrations were determined using a Bradford
Protein Assay Kit (Bio-Rad, Hercules, CA, USA). Analyte levels
of cytokines were measured using the Mouse Pro-inflammatory
7-Plex Ultra-Sensitive Kit (Meso Scale Discovery, Gaithersburg,
MD, USA). During the protocol, plates were washed using the
BioTek ELx405 Select automated liquid handling platform. Imag-
ing of the plates was performed using a Sector 6000 Imager (Meso
Scale Discovery, Gaithersburg, MD, USA). A standard curve for
each analyte was curve-fitted, allowing determination of the con-
centration in pg cytokine/mL sample volume in each well, which
was normalized to total protein input, yielding analyte amount,
expressed as pg cytokine/mg total protein.
MICROARRAY ANALYSES
MouseRef-8 v2.0 Expression BeadChips (Illumina Inc., San Diego,
CA, USA) were used to measure relative levels of mRNA expres-
sion for over 19,000 unique genes. Preparation of cDNA, probe
hybridization, and data collection were carried out at the Cleve-
land Clinic. Background subtracted, quantile normalized data
were analyzed using GenomeStudio (Illumina Inc., San Diego, CA,
USA) and GSEA (Broad Institute, Cambridge, MA, USA) software
packages.
BEHAVIOR STUDIES
All behavior tests were performed on days −1,+1,+3,+7,+10,
+14, and +21, relative to surgical procedures. Rotarod testing
was performed as previously described (Vitali and Clarke, 2004).
Briefly, mice were acclimated to the rotarod apparatus (Ugo Basile,
Collegeville, PA, USA) for 60 s at a fixed speed of 5 rpm. After the
adaptation phase, animals were placed on the rotarod and the
acceleration was increased from 5 to 60 rpm within 180 s. Latency
to fall from the accelerating rotarod and the reached speed were
recorded for each mouse. Three trials were performed for each
animal and the average was reported.
For balance beam testing, mice were placed on a narrow beam
(0.5 cm) and trained to cross the beam for three consecutive days
before the first test. On the testing day, the mice were placed on
the beam and the time spent to cross and the number of foot slips
occurring during the beam cross were recorded. Three trials were
performed for each animal and the average was calculated.
STATISTICAL ANALYSES
Behavior data and protein expression data were analyzed using
one-way analysis of variance (ANOVA) for multiple comparisons
with Tukey’s post hoc test. A two-tailed Student’s t -test was used for
comparison between two groups. Real-time PCR data were ana-
lyzed using a Mann–Whitney test. A p value< 0.05 was considered
statistically significant.
RESULTS
HISTOLOGICAL ANALYSIS OF BRAIN INJURIES
Hematoxylin and eosin staining of coronal sections of brains from
CCI, craniotomy, and naïve animals was performed to assess tis-
sue damage. Low-magnification images revealed severe damage to
the parenchyma of CCI brains, but no obvious tissue disruption
in craniotomy animals (Figure 1A). Higher magnification H&E
images showed immune cell infiltration and/or microglia activa-
tion and expansion around the site of injury, in response to the
severe CCI injury (Figure 1B). Moreover, at the injury site in cran-
iotomy animals, H&E staining suggested immune cell infiltration
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FIGURE 1 | Both severe and mild brain injury is accompanied by a cellular
inflammatory response. (A) H&E staining of coronal sections prepared from
brains of CCI, craniotomy, or naïve animals at day +7. Images were collected
on a Nanozoomer instrument and are displayed at a 2×magnification. *,
injury site. Bar, 2 mm. Cx, cortex; Hi, hippocampus; LV, lateral ventricle; A,
amygdala; Pir, piriform cortex. (B) Tissue sections from (A) are shown at a
40×magnification at the injury site or the equivalent contralateral location, as
indicated. Red outline indicates cortical layer 1, and Green outline indicates
region of altered dura (arrowheads) and underlying tissue at the injury site of
the craniotomy samples. Bar, 100µm. (C) Anti-GFAP immunofluorescence
microscopy analysis of frozen brain sections from CCI, craniotomy, and naïve
animals. Regions imaged were proximal to the injury site. CCI and craniotomy
brains were harvested at day +3. Data are representative of three mice from
each experimental group (naïve, craniotomy, and CCI). Bar, 40µm.
and/or expansion of activated microglia in cortical layer 1 (out-
lined in red), with disruption of the normal architecture of the
dura and underlying cortical cells (outlined in green. Compare to
contralateral sections; Figure 1B). Additionally, immunofluores-
cence microscopy using an anti-GFAP antibody showed evidence
of astrogliosis near the site of injury in both CCI and craniotomy
animals. Specifically, CCI and craniotomy animals had regions of
high astrocyte density and enlarged astrocyte bodies, relative to
naïve controls (Figure 1C). Together, the data in Figure 1 pro-
vide evidence that CCI and craniotomy-induced severe injury and
mild injury to the brain, respectively. Additionally, this histologi-
cal analysis provided evidence of a cellular inflammatory response
following both CCI and craniotomy.
BEHAVIORAL ANALYSIS OF CCI AND CRANIOTOMY ANIMALS
CCI injury and craniotomy were performed directly over the
motor cortex. Post-injury motor function was assessed via rotarod
and balance beam assays (n= 12). In the rotarod task, CCI mice
showed a significant deficit in performance on day +1, com-
pared to pre-injury performance on day −1 (Table 2). Moreover,
Figures 2A,B shows that both the maximum speed attained and
the latency to fall from an accelerating rotarod decreased signifi-
cantly among the CCI mice compared to the craniotomy mice at
days +1 and +3. Although not statistically significant after day
+3, there was a clear and consistent difference between the CCI
and craniotomy animals, which persisted for at least 3 weeks post-
injury (study end). Indeed, craniotomy mice showed no deficit
following surgery, but rather continued to improve their per-
formance throughout the first 2 weeks following injury [naïve
mice show a very similar learning-based improvement over the
same interval (data not shown)]. By day +7, the performance of
CCI mice returned to the baseline level, and this improvement
was statistically significant when comparing day +1 to day +14
(Table 2).
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Table 2 | Statistically significant behavior data.
Assay pValues
ROTAROD, ATTAINED SPEED
CCI day −1 vs. CCI day +1 p<0.05
CCI day +1 vs. CCI day +14 p<0.05
ROTAROD, LATENCYTO FALL
CCI day −1 vs. CCI day +1 p<0.05
CCI day +1 vs. CCI day +14 p<0.05
BALANCE BEAM, CROSSINGTIME
Craniotomy day +1 vs. craniotomy day +3 p<0.05
Craniotomy day +1 vs. craniotomy day +7 p<0.01
Craniotomy day +1 vs. craniotomy day +10 p<0.05
CCI day −1 vs. CCI day +1 p<0.001
CCI day +1 vs. CCI day +3 p<0.001
CCI day +1 vs. CCI day +7 p<0.001
CCI day +1 vs. CCI day +10 p<0.001
CCI day +1 vs. CCI day +14 p<0.001
CCI day +1 vs. CCI day +21 p<0.001
BALANCE BEAM, FOOT SLIPS
Craniotomy day −1 vs. craniotomy day +1 p<0.001
Craniotomy day +1 vs. craniotomy day +3 p<0.01
Craniotomy day +1 vs. craniotomy day +7 p<0.001
Craniotomy day +1 vs. craniotomy day +10 p<0.01
CCI day −1 vs. CCI day +1 p<0.05
CCI day −1 vs. CCI day +3 p<0.001
CCI day +1 vs. CCI day +3 p<0.01
CCI day +3 vs. CCI day +7 p<0.001
CCI day +3 vs. CCI day +10 p<0.001
CCI day +3 vs. CCI day +14 p<0.01
CCI day +3 vs. CCI day +21 p<0.01
Behavior data in Figure 2 were analyzed by ANOVA with Tukey’s multiple com-
parison test. Significant differences between groups (p<0.05) are shown. All
comparisons not shown in this table were not significant, with the exception of
significant CCI vs. craniotomy t-test data (included in Figure 2).
In the balance beam task, both CCI and craniotomy mice
were significantly affected during the first week post-injury
(Figures 2C,D). The crossing time was significantly increased
for CCI animals, comparing day −1 to day +1, and the num-
ber of foot slips was significantly increased on days +1 and
+3 (Table 2). For the craniotomy animals, only the number
of foot slips was significantly increased between day −1 and
+1 (Table 2). Notably, during the first week post-injury, motor
performance was more severely impaired by CCI than by cran-
iotomy. These data were significant for the beam crossing time on
day +7 and for foot slips on days +3 and +7 (Figures 2C,D).
By day +10, both craniotomy and CCI mice showed a signifi-
cant improvement in their performance on the balance beam, vs.
the post-injury day of most severe impairment (Figures 2C,D;
Table 2).
Together, the data in Figure 2 show that the effect of brain
injury on motor function was most pronounced during the first
week post-TBI, with some deficits in function observed for both
CCI and craniotomy animals. The significant differences observed
in the performance of CCI vs. craniotomy animals during the
first week post-injury is consistent with the severe parenchymal
damage induced by CCI vs. the more subtle brain injury induced
by craniotomy (Figure 1).
INFLAMMATORY CYTOKINE PROTEIN RESPONSE TO TRAUMATIC
BRAIN INJURY
Previous studies have established that moderate to severe TBI is
accompanied by inflammation (Ciallella et al., 2002; Harting et al.,
2008; Rhodes et al., 2009; Dalgard et al., 2012). A recent study by
members of our team suggested that there is also significant induc-
tion of several inflammatory mediators in response to mild brain
injury (craniotomy) in the rat model system (Cole et al., 2011). To
determine whether mice also show similar inflammatory responses
to both CCI and craniotomy, we profiled the protein expression
of a subset of cytokines in brain tissue using a multiplexed ELISA
detection platform. For this analysis, we employed a 5 mm punch
biopsy to recover the tissue at the site of CCI and craniotomy, and
from the equivalent site at the non-injured (contralateral) hemi-
spheres. Tissues were harvested from injured animals at days +1,
+3, and+7, and from naïve mice.
Of the seven cytokines measured, six were significantly
increased following CCI, as compared to naïve controls (Figure 3;
Table 3). Of these six cytokines, peak expression was observed
at day +1 for three cytokines (CXCL1, IL-1β, and IL-6), while
the other three cytokines exhibited peak expression at day +3
(IL-12p70, IFN-γ, and IL-10).
In comparing naïve animals to CCI animals at the injury
site, CXCL1 and IL-6 were significantly increased at days +1
and +3, while IL-1β was significantly increased only at day +1.
The craniotomy tissue demonstrated a similar significant increase
in CXCL1 and IL-6 protein expression at day +1, in compari-
son to naïve tissue. The contralateral site did not exhibit sig-
nificant increases in production of these cytokines in CCI or
craniotomy subjects. The exception was CXCL1, which was signif-
icantly increased in craniotomy subjects at day +1, as compared
to controls.
In contrast to CXCL1, IL-1β, and IL-6, the changes in peak
expression for IL-12p70, IFN-γ, and IL-10 after injury were delayed
and modest. Significant increases were detected only at the injury
site. When comparing injured to naïve tissue, IL-12p70, IFN-γ,
and IL-10 were all significantly elevated at day +3, while only IL-
10 was significantly elevated at day+1. After day+3, expression of
these cytokines declined to non-significant levels, vs. naïve. Inter-
estingly, the kinetics of expression of these cytokines in craniotomy
tissue was slower than in CCI tissue, with significant increases of
IL-12p70, IFN-γ, and IL-10 not observed until day+7.
Together, the data in Figure 3 and Table 3 illustrate that
expression of six different cytokines was significantly increased
in response to severe brain injury (CCI). Importantly, expression
of all but one of these cytokines was also significantly increased
at the injury site in response to mild brain injury (craniotomy).
Additionally, the peak levels of cytokine production were similar
(within a factor of three), when comparing CCI vs. craniotomy at
the injury site. Indeed, when comparing each day for CCI to the
corresponding day for craniotomy, the only significant difference
was IL-6 at day +1 (Figure 3; Table 3). Thus, severe brain injury
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FIGURE 2 | Both severe and mild injury induce behavioral deficits.
(A,B) Rotarod assay (n=12). Mice were assessed to determine the
maximum speed attained (A) and the latency to fall (B) during
execution of the accelerating rotarod task (B). (C,D) Balance beam
assay. Mice were assessed for latency to cross the beam (C) and the
number of foot slips during the cross (D). All tests were performed at
day −1, and at multiple time points post-injury over a 21-day period.
Error bars are SEM. The Student’s t -test was used to determine
significance when comparing CCI to craniotomy samples; (* =p<0.05,
† =p<0.005). Significant differences within the CCI and craniotomy
groups were determined using ANOVA with Tukey’s multiple
comparison test (Table 2).
and mild brain injury induce a quantitatively similar inflammatory
cytokine response during the first 7 days post-injury.
MICROARRAY ANALYSIS OF INFLAMMATORY GENE EXPRESSION
To assess whether the above expression data for selected inflam-
matory proteins could be generalized to the global inflamma-
tory response, we performed a genome-wide microarray analysis.
Brain tissue biopsies were collected from CCI, craniotomy, and
naive animals, as described for the cytokine protein analysis in
Figure 3. mRNA was harvested from three to four animals per
time point per condition, and samples from individual animals
were pooled prior to cDNA synthesis. Pooled cDNAs were ana-
lyzed via Illumina bead-chip microarrays. We examined selected
markers of inflammation to assess general trends in inflammatory
gene expression. We chose genes from four diverse functional sets:
inflammatory cytokines, astrocyte activation markers, markers of
antigen presenting cell (APC)/microglia activation, and effectors
of opsonization and phagocytosis. Although a number of different
kinetic patterns were noted, a consistent observation was that the
genes induced by CCI were also induced by craniotomy (Figure 4).
Interestingly, the general gene expression kinetic trends were quite
similar in the CCI and craniotomy groups, with a day +1 or +3
expression peak frequently observed in both groups. For both CCI
and craniotomy groups, induction of inflammatory gene expres-
sion in the contralateral sample was either not detected or less
than that observed in the CCI tissue. However, a general difference
between the CCI and craniotomy groups was that values generally
returned to baseline in the craniotomy group by day +21. In
contrast, the CCI tissues generally remained above the naïve base-
line at day +21. Thus, these data show that inflammation-related
gene expression is highly similar between severe parenchymal
injury (CCI) and mild brain injury (craniotomy), with regard to
the intensity of gene expression and the kinetic pattern of gene
expression. The major notable difference was the persistence of
inflammation in response to severe injury (CCI) at day +21, in
apparent contrast to the mild injury (craniotomy) group.
GENE SET ENRICHMENT ANALYSIS OF MICROARRAY DATA
We also analyzed the microarray data by Gene Set Enrichment
Analysis (GSEA; Subramanian et al., 2005) to determine whether
the patterns of inflammatory gene expression among genes sam-
pled in Figure 4 were representative of the global inflammatory
response to CCI and craniotomy. For this analysis, we chose CCL3
as a representative phenotype among the gene expression pro-
files shown in Figure 4. GSEA software identified gene expression
profiles with similarity to CCL3 and clustered these profiles into
functionally related gene sets. Over 200 gene sets were scored
as enriched, and approximately 100 of these sets were scored as
statistically significant.
Among the sets with highest statistical significance were the
Immune System Process set and the Regulation of IκB Kinase/NF-
κB Cascade set, both of which reflect components of the inflamma-
tory response (Figure 5). For these two sets, the false discovery rate
(FDR) q-values were 0.082 and 0.115, respectively (values< 0.25
Frontiers in Neurology | Neurotrauma October 2012 | Volume 3 | Article 155 | 6
Lagraoui et al. Inflammation in traumatic brain injury
Injury site Contralateral
IL
-1
β
C
X
C
L
1
IL
-6
IL
-1
2
 p
7
0
IF
N
-γ
IL
-1
0
CCI Cran.n
a
iv
e d
1
d
3
d
7
d
1
d
3
d
7
d
1
d
3
d
7
d
1
d
3
d
7
n
a
iv
e
CCI Cran.
c
y
to
k
in
e
 p
ro
te
in
 (
p
g
/m
g
)
*
0.00
0.25
0.50
0.75
1.00
0.00
0.01
0.02
0.03
0.04
0.05
0.00
0.25
0.50
0.75
0
10
20
30
50
40
0.00
0.25
0.50
0.75
1.00
1.25
1.50
1.75
0
5
10
15
FIGURE 3 | Inflammatory cytokines are induced to similar levels by
both severe and mild brain injury. Brain tissue biopsies from the injured
or contralateral sites were harvested from CCI and craniotomy (Cran.)
animals on the indicated days post-injury. Tissues were also harvested
from naïve animals to establish the baseline for each assay. Cytokine
proteins in brain tissue homogenates were quantified by
electrochemiluminescent immunoassay. Three mice from each
experimental group (naïve, craniotomy, and CCI) were used for this
analysis. Error bars are SEM. Statistically significant differences between
groups are indicated inTable 3. Additionally, the single finding of a
statistically significant difference between CCI and craniotomy on
equivalent days is indicated by an asterisk (*).
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Table 3 | Statistically significant changes in cytokine protein levels.
Cytokine measurement pValues
CXCL1 – INJURY SITE
Naive vs. CCI day +1 p<0.001
Naive vs. CCI day +3 p<0.05
Naive vs. craniotomy day +1 p<0.001
Craniotomy day +1 vs. craniotomy day +3 p<0.01
Craniotomy day +1 vs. craniotomy day +7 p<0.01
CXCL1 – CONTRALATERAL SITE
Naive vs. craniotomy day +1 p<0.01
IL-6 – INJURY SITE
Naive vs. CCI day +1 p<0.001
Naive vs. CCI day +3 p<0.01
Naive vs. craniotomy day +1 p<0.05
CCI day +1 vs. CCI day +3 p<0.05
CCI day +1 vs. CCI day +7 p<0.001
CCI day +1 vs. craniotomy day +1 p<0.05
IL-1β – INJURY SITE
Naive vs. CCI day +1 p<0.05
IL-10 – INJURY SITE
Naive vs. CCI day +1 p<0.01
Naive vs. CCI day +3 p<0.001
Naive vs. craniotomy day +7 p<0.05
CCI day+3 vs. CCI day +7 p<0.05
IL-12 p70 – INJURY SITE
Naive vs. CCI day +3 p<0.01
Naive vs craniotomy day +7 p<0.05
IFNγ – INJURY SITE
Naive vs. CCI day +3 p<0.001
Naive vs. craniotomy day +7 p<0.01
CCI day +3 vs. CCI day +7 p<0.05
Cytokine data in Figure 3 were analyzed by ANOVA with Tukey’s multiple com-
parison test. Significant differences between groups (p<0.05) are shown. All
comparisons not shown were not significant.
are considered significant Subramanian et al., 2005). For both sets,
similar trends in gene activation were observed between CCI and
craniotomy animals, with a day +3 activation peak being most
prominent for both CCI (large arrow) and craniotomy (small
arrow). Activation was strong at the injury site, but not detected
or weak at the contralateral site, consistent with the analysis of
selected genes in Figure 4. However, such differences in magni-
tude of activation appeared greatest at day+21, at which point the
CCI-induced RNAs generally remained elevated relative to naïve;
whereas the craniotomy-induced RNAs had generally returned to
the naïve baseline value.
REAL-TIME PCR ANALYSIS OF INFLAMMATORY GENE EXPRESSION
KINETICS
The above microarray data suggested that CCI and craniotomy
induce a highly similar inflammatory gene expression program in
the brain. Moreover, these data suggested that the magnitude of
inflammation-associated gene expression was similar at all time
points through day +7. However, the data also suggested that
the inflammatory gene expression in the CCI and craniotomy
groups diverge by day+21, with robust inflammation maintained
by the CCI animals, but not the craniotomy animals. To confirm
these observations with a more sensitive technique, we used Taq-
Man real-time PCR to quantify relative levels of transcription for
an assortment of eight inflammation-associated genes (Figure 6;
Table 4), which included cytokines (CCL2, IL-1β, TNF-α), mark-
ers of astrocyte activation [Aquaporin-4 (AQP4),Vimentin (VIM),
Matrix metalloproteinase-3 (MMP3)], and RNAs encoding pro-
teins of the macrophage acute phase response [serum amyloid A3
(SAA3), complement C3]. In addition to the days+1,+3,+7, and
+21 time points analyzed in the microarray data, we also included
days +2 and +10. This real-time PCR analysis was performed on
samples from individual mice (3–4 mice/condition/time point),
allowing quantification of biological variability.
Data were quantified as fold-difference in expression for
three ratios: CCI/Naïve, Craniotomy/Naïve, and CCI/Craniotomy
(Figure 6). This analysis generally provided a confirmation of
microarray data presented in Figure 4. For example, in the case
of IL-1β, the peak mRNA levels at the injury site were at day
+1 for both CCI and craniotomy. Also, the IL-1β mRNA levels
at the injury site for the CCI samples at day +1 was approxi-
mately 2× higher by microarray vs. 4× higher by real-time PCR,
as compared to the craniotomy samples. For certain transcripts,
such as CCL2, the real-time PCR provided much higher signal-to-
noise than the microarray analysis, revealing a strong induction
of CCL2 transcription by craniotomy that was not evident in the
microarray data. Also, the inclusion of additional time points in the
real-time PCR analysis revealed important details of the kinetics
for the expression of certain genes. For example, day +10 repre-
sents the peak AQP4 and C3 mRNA expression (among included
time points) at the injury site for CCI animals. Day+10 also repre-
sents a secondary peak of transcription of CCL2 and IL-1β genes,
in response to CCI.
Importantly, the real-time PCR analysis confirmed the overall
trend suggested by the microarray analyses (Figures 4 and 5).
Specifically, at the site of injury, whereas inflammatory gene
expression persisted beyond day+7 (and in some cases continued
to intensify) in the CCI animals, inflammatory gene expression
in the craniotomy animals generally reached or approached base-
line values beyond day +7. This trend was particularly apparent
when assessing the CCI/craniotomy ratios for the injury site data,
in which the greatest difference between CCI and craniotomy was
at day +10 or +21 for all eight mRNAs. Moreover, whereas the
majority of transcripts exhibited less than a 10-fold difference in
the CCI/craniotomy ratio between days +1 and +7, three genes
(MMP3, SAA3, and C3) showed a greater than 50-fold difference
between mRNA abundance in CCI and craniotomy animals at
day +10 or +21 (note, however, that the MMP3 data were not
significant, due to high variability at these late time points).
Notably, for all transcripts except for MMP3, statistically
significant differences were observed between CCI and cran-
iotomy tissues (at the injury site) for day +10 and/or +21.
Although significant differences between these same groups were
also seen at day +1 for five transcripts (IL-1β, TNFα, VIM,
MMP3, and C3), it is important to note that the fold-differences
were greater at day +10 and/or +21. Together, these data rein-
force the conclusions suggested by Figures 3 and 5. Specifically,
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FIGURE 4 | Microarray analysis shows severe and mild brain injury
induce expression of multiple inflammation-related transcripts with
similar kinetics. Injury site and contralateral site biopsies were harvested
from CCI and craniotomy mice at the indicated times post-injury. Brain tissue
was also harvested from naïve animals. Total RNA samples from individual
animals from each experimental group (3–4 mice/group) were pooled, and
cDNA was synthesized and analyzed by microarray. Relative expression levels
are shown for selected genes in the indicated functional groups.
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FIGURE 5 | Gene set enrichment analysis (GSEA) confirms induction of
a broad inflammatory response by both severe and mild injury.
Microarray data were analyzed using GSEA software to identify functionally
related groups of genes (gene sets) with statistically significant enrichment,
using CCL3 as the gene expression phenotype. The figure shows the
enrichment plot and the top 25 enriched genes for (A) the Immune System
Process set and (B) the Regulation of NF-κB Signaling (Regulation of IκB
kinase/NF-κB Cascade) set. The plot on the left shows the distribution of
genes in the set that are positively and negatively correlated with the CCL3
phenotype. The plot on the right shows the relative gene expression
(red=high, blue= low) for each gene for the indicated samples. Note that
the overall kinetic profiles are similar for the CCI and craniotomy (Cran)
samples, with a prominent gene expression peak at day +3 (large and small
arrows indicate the day +3 peak for CCI and craniotomy, respectively).
However, the craniotomy samples generally show a lower intensity of gene
expression, particularly at day +21.
severe brain injury and mild brain injury induce very similar
inflammatory responses through approximately day +7. Follow-
ing day +7 (during the period of days +10 through +21 in
our analysis), the inflammatory response to severe injury persists,
whereas the response to mild injury returns to baseline for most
genes.
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FIGURE 6 |The inflammatory response to severe brain injury persists for
several weeks, whereas the response to mild injury declines rapidly after
day +7. Real-time PCR analysis of mRNA levels for the indicated genes at
days +1, +2, +3, +7, +10, and +21. Samples from individual animals from
both ipsilateral and contralateral sites were tested for the expression of the
specified genes. Three or four mice were analyzed for each time point in each
experimental group. Data are expressed as ratios of CCI/Naïve,
Craniotomy/Naïve, and CCI/Craniotomy, as indicated, with the y -axis
indicating fold-difference in gene expression. Note that the CCI/Craniotomy
fold-difference at the injury site is greatest after day +7 for all analyzed genes.
Significant differences in mRNA levels in the CCI vs. Craniotomy groups are
listed inTable 4. Error bars are SEM.
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Table 4 | Statistically significant changes in gene expression.
Assay pValues
CCL2 – INJURY SITE
CCI vs. craniotomy – day+10 p<0.05
CCI vs. craniotomy – day+21 p<0.05
IL-1β – INJURY SITE
CCI vs. craniotomy – day+1 p<0.05
CCI vs. craniotomy – day+10 p<0.05
TNFα – INJURY SITE
CCI vs. craniotomy – day+1 p<0.05
CCI vs. craniotomy – day+10 p<0.05
CCI vs. craniotomy – day+21 p<0.05
AQP4 – INJURY SITE
CCI vs. craniotomy – day+7 p<0.05
CCI vs. craniotomy – day+10 p<0.05
CCI vs. craniotomy – day+21 p<0.05
VIM – INJURY SITE
CCI vs. craniotomy – day+1 p<0.0001
CCI vs. craniotomy – day+2 p<0.05
CCI vs. craniotomy – day+10 p<0.05
CCI vs. craniotomy – day+21 p<0.05
MMP3 – INJURY SITE
CCI vs. craniotomy – day+1 p<0.05
SAA3 – INJURY SITE
CCI vs. craniotomy – day+10 p<0.05
CCI vs. craniotomy – day+21 p<0.05
C3 – INJURY SITE
CCI vs. craniotomy – day+1 p<0.05
CCI vs. craniotomy – day+7 p<0.05
CCI vs. craniotomy – day+21 p<0.05
Real-time PCR data in Figure 6 were analyzed using a Mann–Whitney test. Sig-
nificant differences between CCI and craniotomy groups (p<0.05) are shown.
All comparisons not shown were not significant.
DISCUSSION
In this study, we performed a 21-day kinetic analysis of the inflam-
matory response to severe and mild brain injury, examining both
the injury site and the equivalent site on the contralateral hemi-
sphere. The histological data in Figure 1 support the severe nature
of the CCI injury and the more subtle nature of injury-associated
with craniotomy. Specifically, CCI-induced a substantial loss of
brain tissue beneath the injury site, accompanied by consider-
able inflammatory cell infiltration and astrocyte activation. In
contrast, the craniotomy animals showed no evidence of tissue
loss. However, craniotomy was not innocuous, as demonstrated
by histological changes within the injury site: H&E staining of
coronal sections showed increased numbers of inflammatory cells
and changes to the dura and underlying parenchyma. Anti-GFAP
immunofluorescence suggested astrogliosis. Thus, although there
was no apparent brain tissue loss due to craniotomy, there was
clear evidence of an inflammatory response.
Behavior data (Figure 2) showed a clear difference in impair-
ment of motor function in CCI vs. craniotomy animals. Between
day −1 and day +1, only the CCI animals exhibited a significant
impairment in performance in the rotarod assay, whereas both
injuries significantly impaired performance on the balance beam.
Thus, both severe and mild injury to the motor cortex cause at
least a transient functional impairment. However, direct compari-
son of CCI vs. craniotomy animals revealed significant differences
on days+1 and+3 for the rotarod, and on days+3 and+7 for the
balance beam. Based on these data, we conclude that craniotomy
induces a mild and transient functional impairment, while CCI
more severely impairs function for at least a week post-injury. The
behavior data are consistent with the histological data (Figure 1).
Quantification of protein levels for a limited selection of
inflammatory cytokines also supported the histological data. In
comparison to naïve controls, there was a significant elevation of
each of the measured inflammatory cytokines at one or more time
points at the injury site in both the CCI and craniotomy groups
(with the exception of IL-1β, for which the measured increase
did not reach significance in the craniotomy group). Although
increases in cytokine expression were generally confined to the
site of injury, it is notable that in one instance (CXCL1 at day
+1), we did detect a significant increase at the contralateral site in
the craniotomy group. This finding suggests that certain cytokines
diffuse over considerable distances following brain injury, and/or
that long-range diffusion of hidden self-antigens stimulates res-
ident pro-inflammatory cells (e.g., microglia and astrocytes) far
from the site of injury. The mRNA expression data in Figures 4
and 6 are suggestive of the latter possibility.
Surprisingly, over the first week post-injury, the levels of inflam-
matory protein expression in the CCI and craniotomy groups were
of similar magnitude, even though the extent of tissue damage
was substantially different. Indeed, the only statistically significant
difference between CCI and craniotomy was for IL-6 at day +1.
These data suggest that major differences in the extent of brain
tissue injury are reflected by modest differences in inflammatory
cytokine production.
Because our cytokine protein analysis included a limited num-
ber of inflammatory mediators, we performed a genome-wide
microarray analysis. The microarray data confirmed and extended
the cytokine protein measurements. Specifically, these data showed
that CCI and craniotomy induce the transcription of an identical
or highly overlapping set of soluble and cell-associated regula-
tors of inflammation. Furthermore, the kinetics and magnitude of
induction of these genes was highly similar during the first week
post-injury. Therefore, through day +7, there is little difference
between the global inflammatory response induced by a severe
brain lesion with substantial tissue destruction vs. a mild brain
injury with minimal damage to the parenchyma.
Importantly, however, our data show that following day+7, the
inflammatory responses to severe and mild brain injury become
discordant. In general, inflammatory gene expression persisted
thorough at least day +21 in the CCI group, while returning to
naïve baseline levels in the craniotomy animals by day +10. We
presume that this difference reflects both the time required for
phagocytic cells to clear dead tissue and the ongoing cell death (and
concomitant pro-inflammatory signaling by persistent release of
hidden self-antigens) in the penumbral region surrounding the
site of direct tissue damage (Fitch and Silver, 2008; Loane and
Byrnes, 2010) in the severe injury (CCI) group. Not only did the
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CCI animals exhibit persistent (≥21 days) expression of the great
majority of measured inflammation-associated genes, but a subset
of genes, including complement C3, reached their peak expression
after day+7.
In general, the mRNA and protein expression data are con-
sistent with the behavior data: the greatest behavioral deficit
correlated with the peak of the inflammatory response. Such a
finding is consistent with the phenomenon of cytokine-induced
sickness behavior, in which pro-inflammatory cytokines interact
with the brain, inducing broad behavioral changes (Dantzer, 2001;
Capuron and Miller, 2011). Based on our behavior data (which
showed no significant behavioral deficit beyond day +7), it is not
clear whether the persistent inflammatory response in CCI animals
is correlated with any functional deficits. As the CCI injury resulted
in clear tissue destruction, it is also difficult to assess the degree
to which cell loss vs. inflammation contributed to the observed
phenotypes. To better assess the relationship between inflamma-
tion and functional deficits, it will thus be important to develop
TBI models that yield persistent inflammation with minimal tissue
destruction, for testing with a wide array of behavioral assays.
We are not aware of detailed kinetic assessments of the global
inflammatory response following other types of TBI, although the
limited existing data are in general agreement with our findings.
Specifically, a recent study using a mouse model of blast injury
(Cernak et al., 2011) included semi-quantitative PCR findings con-
sistent with our data. Measurements of CCL2 in the hippocampus
and brainstem and GFAP in the hippocampus showed significant
elevation of transcription in response to moderate blast, persisting
until at least day+30 (study end). Mild blast also caused increased
transcription of these genes, with day +1 levels very similar to
moderate blast. However, by day +30, mRNA levels in the mild
blast animals returned to baseline. Thus, the relationship between
the inflammatory response induced by mild blast vs. moderate
blast may be analogous to the relationship between craniotomy
and CCI.
Regarding closed-head concussive injury models (weight drop
or impactor device), investigators have reported transient increases
in transcription of inflammatory genes (Crack et al., 2009; Israels-
son et al., 2009) and persistent activation of microglia (Venkatesan
et al., 2010). Another study failed to detect significant elevations
of inflammatory cytokine proteins (Semple et al., 2010), although
there were trends toward elevation of inflammatory mediators
at early times post-injury. Because of differences in injury deliv-
ery, time points assessed, and analytical methods, it is difficult
to distil these data to a consensus finding regarding inflamma-
tion following closed-head concussive injury. In general, however,
these studies do suggest the induction of a transient inflammatory
response, with peak expression by day+1 or day+3.
Although we speculate that repeated closed-head injury will
trigger a more persistent inflammatory state in the brain, we are
not aware of published data addressing this prediction. Given
the accumulating clinical data showing striking pathology result-
ing from repeated concussive injuries (Baugh et al., 2012), it
will be important to determine whether persistent inflammation
contributes to the neurodegenerative response associated with
repeated closed-head concussive injury.
With the increasing focus on TBI resulting from military
deployments, concussion-prone sports, and auto accidents, many
investigators are attempting to develop minimally invasive strate-
gies to assess the extent and/or severity of brain damage result-
ing from a known or suspected recent TBI (Kubal, 2012). As
inflammation is a predictable response to brain injury, mea-
surement of inflammation is being explored as a proxy for
brain damage. Specific approaches include the use of probes
to detect activated macrophages in the brain through mag-
netic resonance imaging (MRI) and positron emission tomogra-
phy (PET; Stoll and Bendszus, 2009; Wunder et al., 2009; Sib-
son et al., 2011), and use of antibody-based assays to detect
biomarkers of inflammation in the blood or cerebral-spinal
fluid (Agoston et al., 2009; Korfias et al., 2009; Svetlov et al.,
2009). However, our data illustrate that such strategies, when
employed as single time point tests within the first week of
injury, may be unable to accurately assess the severity of brain
tissue injury. Based on our data, we predict that accurate
quantification of TBI severity will require repeated measures
of inflammation performed over a period of at least 10 days.
We furthermore propose that those inflammation-associated
genes which show peak expression after day +7 may represent
ideal biomarkers of TBI severity. This idea will require further
validation.
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